Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity as clinical predictors of effectiveness Read More > September 5, 2018
d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders. Read More > August 31, 2018
Therapeutic Potential Ascribed to Ayahuasca by Users in the Czech Republic Read More > August 30, 2018
Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress Read More > August 13, 2018
Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition Read More > July 30, 2018
Efficacy of Ketamine in the Treatment of Substance Use Disorders: A Systematic Review Read More > July 24, 2018
Ketamine normalizes brain activity during emotionally valenced attentional processing in depression Read More > July 5, 2018
